Clinical Trial Update: The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

View source ↗

Summary

A clinical trial examining whether plasma metabolite profiles relate to risk, efficacy, and prognosis in early breast cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Shengjing Hospital | Conditions: Breast Cancer | Status: RECRUITING